
Cerner Corporation CERN
Quarterly report 2022-Q1
added 05-16-2026
Cerner Corporation ROA Ratio 2011-2026 | CERN
Annual ROA Ratio Cerner Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.47 | 10.37 | 7.68 | 9.39 | 13.4 | 11.31 | 3.25 | - | 9.72 | 10.72 | 10.22 | 2.83 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 | 2.83 | 8.76 |
Quarterly ROA Ratio Cerner Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.55 | 5.55 | 5.55 | 7.73 | 4.93 | 6.81 | 9.33 | 10.86 | 10.87 | 11.23 | 7.56 | 7.35 | 7.54 | 7.26 | 8.57 | 9.42 | 9.5 | 12.75 | 13.1 | 13.47 | 14.0 | 11.46 | 11.47 | 11.38 | 11.08 | 11.69 | 11.5 | 10.72 | 10.1 | 9.77 | 10.13 | 10.89 | 8.81 | 10.28 | 10.25 | 10.16 | 10.23 | 11.79 | 11.73 | 11.76 | 11.66 | 11.68 | 11.6 | 11.29 | 10.98 | 10.52 | 10.22 | 2.52 | 2.58 | 2.47 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.0 | 2.47 | 9.59 |
ROA Ratio of other stocks in the Health information services industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-10.65 | - | 0.29 % | $ 206 M | ||
|
Evolent Health
EVH
|
-30.51 | $ 3.95 | 1.28 % | $ 451 M | ||
|
Change Healthcare
CHNG
|
-0.58 | - | - | $ 9.03 B | ||
|
Computer Programs and Systems
CPSI
|
1.08 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-1.58 | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
-37.29 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
5.28 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
1.15 | - | - | $ 6.37 B | ||
|
HealthEquity
HQY
|
6.37 | $ 87.99 | -2.79 % | $ 7.58 B | ||
|
iCAD
ICAD
|
-14.96 | - | - | $ 102 M | ||
|
GoodRx Holdings
GDRX
|
2.17 | $ 2.92 | -1.68 % | $ 1.04 B | ||
|
Akerna Corp.
KERN
|
-12.29 | - | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
-21.56 | - | -10.39 % | $ 886 M | ||
|
10x Genomics
TXG
|
-4.18 | $ 28.31 | 1.13 % | $ 3.53 B | ||
|
MTBC
MTBC
|
0.01 | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
-16.35 | - | - | $ 3.37 B | ||
|
NextGen Healthcare
NXGN
|
1.48 | - | - | $ 1.6 B | ||
|
Premier
PINC
|
0.58 | - | - | $ 2.33 B | ||
|
Health Catalyst
HCAT
|
-35.41 | $ 1.38 | -1.43 % | $ 96.5 M | ||
|
OptimizeRx Corporation
OPRX
|
2.9 | $ 5.19 | 1.76 % | $ 96.3 M | ||
|
Schrödinger
SDGR
|
-14.22 | $ 15.2 | 7.34 % | $ 1.12 B | ||
|
Phreesia
PHR
|
0.35 | $ 9.86 | 4.34 % | $ 589 M | ||
|
R1 RCM
RCM
|
6.71 | - | - | $ 3.81 B | ||
|
Teladoc Health
TDOC
|
-7.01 | $ 7.61 | 1.33 % | $ 1.34 B | ||
|
Signify Health
SGFY
|
-33.07 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-28.55 | - | - | $ 21.4 M | ||
|
NantHealth
NH
|
-42.48 | - | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
-56.28 | - | - | $ 7.71 M | ||
|
American Well Corporation
AMWL
|
-29.56 | $ 9.83 | 3.91 % | $ 158 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-38.4 | - | - | $ 255 M | ||
|
HealthStream
HSTM
|
3.52 | $ 24.97 | 1.38 % | $ 750 M | ||
|
Omnicell
OMCL
|
0.1 | $ 44.14 | -1.3 % | $ 2.03 B | ||
|
Progyny
PGNY
|
7.88 | $ 25.56 | -0.51 % | $ 2.18 B | ||
|
So-Young International
SY
|
-9.14 | $ 1.95 | - | $ 152 M | ||
|
Veeva Systems
VEEV
|
10.12 | $ 174.34 | 6.06 % | $ 28.5 B | ||
|
Zhongchao
ZCMD
|
-26.13 | $ 0.17 | -69.09 % | $ 581 K |